US Patent Issued to Biotheranostics, The General Hospital on Nov. 4 for "Post-treatment breast cancer prognosis" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,265, issued on Nov. 4, was assigned to Biotheranostics Inc. (San Diego) and The General Hospital Corp. (Boston).

"Post-treatment breast cancer prognosis" was invented by Dennis Sgroi (Cambridge, Mass.), Mark G. Erlander (Carlsbad, Calif.), Yi Zhang (San Diego) and Catherine A. Schnabel (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure includes the identification and use of gene expression profiles, or patterns, with clinical relevance to extended treatment and cancer-free survival in a patient. In particular, the disclosure includes the identities of genes that are expressed in correlation with benefit in a switch in endocrine ...